Literature DB >> 21611975

Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients.

Hartmut H Malluche1, Hanna W Mawad, Marie-Claude Monier-Faugere.   

Abstract

Renal osteodystrophy occurs early during loss of kidney function. There are 26 million American patients with chronic kidney disease (CKD), and almost all patients with CKD stage 5 have abnormal bone histology. Six hundred and thirty bone biopsies from adult CKD-5 patients on dialysis were evaluated by histomorphometry and analyzed using the turnover (T), mineralization (M), and volume (V) classification. There were racial differences; whites exhibited predominantly low turnover (62%), whereas blacks showed mostly normal or high turnover (68%). A mineralization defect was observed in only 3% of patients. In whites, cancellous bone volume was low, normal, or high in approximately the same number of patients, whereas in blacks, cancellous bone volume was high in two-thirds of the patients. More than 80% of blacks and whites with low cancellous bone volume had thin trabeculae owing to low bone formation. Cortical thickness was low in half the whites, whereas it was normal in three-quarters of blacks. Cortical porosity was high in 50% of whites, whereas three-quarters of blacks had high porosity. In summary, the TMV system gives relevant information. It should be expanded to include the architecture of cancellous and cortical bone. There are racial differences. Low bone volume and low bone turnover are more frequent than heretofore appreciated, whereas mineralization defects nowadays are observed rarely in adults. These findings call for an adjustment of the current therapeutic paradigm that takes into consideration race and risk of low bone volume and turnover. The latter have been shown to be associated with increased vascular calcifications.
Copyright © 2011 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Year:  2011        PMID: 21611975      PMCID: PMC3312761          DOI: 10.1002/jbmr.309

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  42 in total

1.  Renal osteodystrophy: what's in a name? Presentation of a clinically useful new model to interpret bone histologic findings.

Authors:  H H Malluche; M C Monier-Faugere
Journal:  Clin Nephrol       Date:  2006-04       Impact factor: 0.975

2.  A modification of the masson trichrome technique for routine laboratory purposes.

Authors:  J Goldner
Journal:  Am J Pathol       Date:  1938-03       Impact factor: 4.307

3.  Bone mass in maintenance haemodialysis. Prospective study with sequential biopsies.

Authors:  H H Malluche; E Ritz; H P Lange; D Arras; W Schoeppe
Journal:  Eur J Clin Invest       Date:  1976-07-30       Impact factor: 4.686

4.  Histomorphometric assessment of bone mass, structure, and remodeling: a comparison between healthy black and white premenopausal women.

Authors:  M Parisien; F Cosman; D Morgan; M Schnitzer; X Liang; J Nieves; L Forese; M Luckey; D Meier; V Shen; R Lindsay; D W Dempster
Journal:  J Bone Miner Res       Date:  1997-06       Impact factor: 6.741

5.  Stiffness of compact bone: effects of porosity and density.

Authors:  M B Schaffler; D B Burr
Journal:  J Biomech       Date:  1988       Impact factor: 2.712

6.  Age-related changes in the tensile properties of cortical bone. The relative importance of changes in porosity, mineralization, and microstructure.

Authors:  R W McCalden; J A McGeough; M B Barker; C M Court-Brown
Journal:  J Bone Joint Surg Am       Date:  1993-08       Impact factor: 5.284

7.  Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.

Authors:  H H Malluche; D A Goldstein; S G Massry
Journal:  Contrib Nephrol       Date:  1980       Impact factor: 1.580

8.  Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate.

Authors:  T Freemont; H H Malluche
Journal:  Clin Nephrol       Date:  2005-02       Impact factor: 0.975

9.  Risk of adynamic bone disease in dialyzed patients.

Authors:  H H Malluche; M C Monier-Faugere
Journal:  Kidney Int Suppl       Date:  1992-10       Impact factor: 10.545

10.  Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.

Authors:  M Wang; G Hercz; D J Sherrard; N A Maloney; G V Segre; Y Pei
Journal:  Am J Kidney Dis       Date:  1995-11       Impact factor: 8.860

View more
  105 in total

1.  High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.

Authors:  Hartmut H Malluche; Gustav Blomquist; Marie-Claude Monier-Faugere; Thomas L Cantor; Daniel L Davenport
Journal:  J Am Soc Nephrol       Date:  2015-04-02       Impact factor: 10.121

Review 2.  Adynamic bone disease is a predominant bone pattern in early stages of chronic kidney disease.

Authors:  Ziad Massy; Tilman Drueke
Journal:  J Nephrol       Date:  2017-04-12       Impact factor: 3.902

3.  Biomarkers of Bone Turnover Identify Subsets of Chronic Kidney Disease Patients at Higher Risk for Fracture.

Authors:  Jan M Hughes-Austin; Ronit Katz; Richard D Semba; Stephen B Kritchevsky; Douglas C Bauer; Mark J Sarnak; Charles Ginsberg; Michael G Shlipak; Florence Lima; Hartmut H Malluche; Joachim H Ix
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

4.  Genetic African Ancestry and Markers of Mineral Metabolism in CKD.

Authors:  Orlando M Gutiérrez; Afshin Parsa; Tamara Isakova; Julia J Scialla; Jing Chen; John M Flack; Lisa C Nessel; Jayanta Gupta; Keith A Bellovich; Susan Steigerwalt; James H Sondheimer; Jackson T Wright; Harold I Feldman; John W Kusek; James P Lash; Myles Wolf
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-08       Impact factor: 8.237

Review 5.  Bone Disease after Kidney Transplantation.

Authors:  Antoine Bouquegneau; Syrazah Salam; Pierre Delanaye; Richard Eastell; Arif Khwaja
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-15       Impact factor: 8.237

6.  Renal complications in multiple myeloma and related disorders: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

Authors:  Beth M Faiman; Patricia Mangan; Jacy Spong; Joseph D Tariman
Journal:  Clin J Oncol Nurs       Date:  2011-08       Impact factor: 1.027

7.  Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy.

Authors:  Syazrah Salam; Orla Gallagher; Fatma Gossiel; Margaret Paggiosi; Arif Khwaja; Richard Eastell
Journal:  J Am Soc Nephrol       Date:  2018-03-19       Impact factor: 10.121

8.  Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone.

Authors:  Renata C Pereira; Isidro B Salusky; Richard E Bowen; Earl G Freymiller; Katherine Wesseling-Perry
Journal:  Bone       Date:  2019-08-01       Impact factor: 4.398

9.  Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease.

Authors:  Daniel Cejka; Diego Parada-Rodriguez; Stefanie Pichler; Rodrig Marculescu; Ina Kramer; Michaela Kneissel; Thomas Gross; Andreas Reisinger; Dieter Pahr; Marie-Claude Monier-Faugere; Martin Haas; Hartmut H Malluche
Journal:  Kidney Int       Date:  2016-08-12       Impact factor: 10.612

Review 10.  Updates in CKD-Associated Osteoporosis.

Authors:  Pascale Khairallah; Thomas L Nickolas
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.